Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | BNA035 |
Synonyms | |
Therapy Description |
BNA035 is a bi-specific antibody that binds EGFR and 4-1BB, potentially resulting in increased anti-tumor immune response and lysis of tumor cells expressing EGFR (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BNA035 | BNA-035|BNA 035|HLX35|HLX 35|HLX-35 | EGFR Antibody 56 TNFRSF9 Antibody 30 | BNA035 is a bi-specific antibody that binds EGFR and 4-1BB, potentially resulting in increased anti-tumor immune response and lysis of tumor cells expressing EGFR (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05150457 | Phase I | BNA035 | Safety and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors | Recruiting | AUS | 0 |